Novel Reagent Using Spectrophotometry
Sensitive detection of iron (II) sulfate with a novel reagent using spectrophotometry
- A synthesized thio-anthraquinone analogue (3) was purified by column chromatography, and its chemical structure was characterized by spectroscopic methods such as Fourier-transform infrared spectroscopy (FT-IR), nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and ultraviolet (UV)-visible spectrophotometry.
- The chemical and molecular structure of the developed thio-antraquinone derivative (3) was illuminated using computational methods with the GaussView5 and Gaussian09 programs. Various solvents including ethanol, methanol, and acetonitrile were examined in the preparation of the reagent. A concentration range from 0.2 mg mL-1 up to 10 mg mL-1 of iron (II) sulfate heptahydrate solution in distilled water was prepared. The absorption spectra of Catal’s reagent (0.816 mM) showed three peaks between 185 nm-700 nm of wavelength.
- However, after the reaction with H2O2 and the 30 mM trisodium citrate dihydrate mixture in the presence of an iron sulfate (II) solution, a single peak was observed, producing a stable and reddish/brownish homogenous solution (λ max = 304 nm).
- The following concentrations of iron (II) sulfate heptahydrate was examined using developed protocol and the reagent, and the concentrations were measured spectrophotometrically at 304 nm, 0.2-1 mg mL-1. Absorbances of reaction mixtures of iron (II) sulfate remained stable up to 48 h.
- The results indicated that the novel Catal’s reagent can be used for sensitive spectrophotometric detection of iron (II) sulfate in aqueous solutions.

gentaur
CryoProtX Mix Reagents 1.5 mL |
|||
| M-MDSR-61 | MiTeGen | 1.5 ml ml | EUR 37 |
|
Description: CryoProtX Mix Reagents 1.5 mL |
|||
Set of 10 Biolipidure Reagents |
|||
| Biolipidure-set | AS ONE International | 10mLx10 | EUR 1820.4 |
|
Description: Set of 10 Biolipidure Reagents, whose applications include Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
REAGENTS HIGH RANGE AMMONIA - PK25 |
|||
| HI73325 | Scientific Laboratory Supplies | PK25 | EUR 55.35 |
High Range Ammonia Reagents - EACH |
|||
| HI9373301 | Scientific Laboratory Supplies | EACH | EUR 130.95 |
Human CD34 ELISA Construction kit w/Developing Reagents & Plates |
|||
| RHF661CKP | Antigenix America | - | Ask for price |
CryoProtX Mix Eco Reagents 1.5 mL |
|||
| M-MDSR-61-ECO | MiTeGen | 1.5 ml ml | EUR 37 |
|
Description: CryoProtX Mix Eco Reagents 1.5 mL |
|||
PeliKine tool set, additional reagents |
|||
| M1980 | Tecan Benelux | 1 unit | EUR 169.8 |
Alkphos Direct Labelling Reagents - EACH |
|||
| RPN3680 | Scientific Laboratory Supplies | EACH | EUR 915.3 |
Macro & Micro-Test Sample Release Reagent |
|||
| 3005 | Macro & Micro-Test Med-Tech | 1 Each | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8A | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8B | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8C | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8D | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8E | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8F | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8G | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8H | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8J | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Macro & Micro-Test Sample Release Reagent |
|||
| HWTS-3005-8L | Macro & Micro-Test Med-Tech | 1 Kit | Ask for price |
Human VAP-1 w/Developing Reagents |
|||
| RHF655CKC | Antigenix America | - | Ask for price |
BSA Standards for quantification reagents |
|||
| BM0100 | Expedeon | 100000 Units in 2x 200 µL | Ask for price |
Human SCGF Alpha w/Developing Reagents |
|||
| RHF664CKC | Antigenix America | - | Ask for price |
Macro & Micro-Test Sample Release Reagent (CRE) |
|||
| 3009 | Macro & Micro-Test Med-Tech | 1 Each | Ask for price |
Free Chlorine Reagents 0-5mg/L - EACH |
|||
| WAT1028 | Scientific Laboratory Supplies | EACH | EUR 49.95 |
pH-sensitive IgG labeling reagents plus |
|||
| UA070080 | Starter Biotechnology Co Ltd |
|
|
Human TGF beta-3 w/Developing Reagents |
|||
| RHF643CKC | Antigenix America | - | Ask for price |
iN-fect™ In vitro transfection reagents |
|||
| 15081 | iNtRON Biotechnology Inc | 500 µL | EUR 127.27 |
|
Description: Transfection |
|||
Pre-Titrated Reagents for Human EGF ELISA |
|||
| MBS590076-10Plates | MyBiosource | 10Plates | EUR 710 |
Pre-Titrated Reagents for Human EGF ELISA |
|||
| MBS590076-5Plates | MyBiosource | 5Plates | EUR 520 |
Pre-Titrated Reagents for Human EGF ELISA |
|||
| MBS590076-5x10Plates | MyBiosource | 5x10Plates | EUR 3270 |
Human VAP-1 w/Developing Reagents & Plates |
|||
| RHF655CKP | Antigenix America | - | Ask for price |
Bradford(Coomassie) Protein Assay Plus Reagents |
|||
| P7201-050 | GenDepot | 450ml | EUR 118 |
Bradford(Coomassie) Protein Assay Plus Reagents |
|||
| P7201-100 | GenDepot | 950ml | EUR 130 |
Human Adiponectin ELISA w/Developing Reagents |
|||
| RHF651CKC | Antigenix America | - | Ask for price |
Human Uteroglobin ELISA w/Developing Reagents |
|||
| RHF656CKC | Antigenix America | - | Ask for price |
Human SCGF Alpha w/Developing Reagents & Plates |
|||
| RHF664CKP | Antigenix America | - | Ask for price |
Rat EGF Construction Kit w/Developing Reagents |
|||
| RRF312CKC | Antigenix America | - | Ask for price |
Rat SCF Construction Kit w/Developing Reagents |
|||
| RRF432CKC | Antigenix America | - | Ask for price |
COMBI IC Reagent: Mouse anti CD45 (FITC) and Mouse anti CD14 (PE) |
|||
| MBS570370-50Tests | MyBiosource | 50Tests | EUR 450 |
COMBI IC Reagent: Mouse anti CD45 (FITC) and Mouse anti CD14 (PE) |
|||
| MBS570370-5x50Tests | MyBiosource | 5x50Tests | EUR 1885 |
Liposomal and Non-Liposomal Transfection Reagents |
|||
| abx298032-100g | Abbexa | 100 µg | Ask for price |
Liposomal and Non-Liposomal Transfection Reagents |
|||
| abx298032-20g | Abbexa | 20 µg | EUR 875 |
Liposomal and Non-Liposomal Transfection Reagents |
|||
| abx298032-50g | Abbexa | 50 µg | Ask for price |
Mouse KC Construction Kit w/Developing Reagents |
|||
| RMF428CKC | Antigenix America | - | Ask for price |
Rat CNTF Construction Kit w/Developing Reagents |
|||
| RRF426CKC | Antigenix America | - | Ask for price |
Pre-Titrated Reagents for Human IL-8 ELISA |
|||
| MBS590074-10Plates | MyBiosource | 10Plates | EUR 710 |
Pre-Titrated Reagents for Human IL-8 ELISA |
|||
| MBS590074-5Plates | MyBiosource | 5Plates | EUR 520 |
Pre-Titrated Reagents for Human IL-8 ELISA |
|||
| MBS590074-5x10Plates | MyBiosource | 5x10Plates | EUR 3270 |
Human MIA Construction Kit w/Developing Reagents |
|||
| RHF127CKC | Antigenix America | - | Ask for price |
Human GRO Construction Kit w/Developing Reagents |
|||
| RHF250CKC | Antigenix America | - | Ask for price |
Human EGF Construction Kit w/Developing Reagents |
|||
| RHF290CKC | Antigenix America | - | Ask for price |
Human MIG Construction Kit w/Developing Reagents |
|||
| RHF450CKC | Antigenix America | - | Ask for price |
Human NOV Construction Kit w/Developing Reagents |
|||
| RHF464CKC | Antigenix America | - | Ask for price |
Human SCF Construction Kit w/Developing Reagents |
|||
| RHF540CKC | Antigenix America | - | Ask for price |
Human TPO Construction Kit w/Developing Reagents |
|||
| RHF570CKC | Antigenix America | - | Ask for price |
Human LEC Construction Kit w/Developing Reagents |
|||
| RHF690CKC | Antigenix America | - | Ask for price |
Human MDC Construction Kit w/Developing Reagents |
|||
| RHF700CKC | Antigenix America | - | Ask for price |
Human MEC Construction Kit w/Developing Reagents |
|||
| RHF785CKC | Antigenix America | - | Ask for price |
Human LIF Construction Kit w/Developing Reagents |
|||
| RHF856CKC | Antigenix America | - | Ask for price |
Human OPG Construction Kit w/Developing Reagents |
|||
| RHF907CKC | Antigenix America | - | Ask for price |
Mouse SCF Construction Kit w/Developing Reagents |
|||
| RMF322CKC | Antigenix America | - | Ask for price |
Mouse MDC Construction Kit w/Developing Reagents |
|||
| RMF363CKC | Antigenix America | - | Ask for price |
Mouse LIX Construction Kit w/Developing Reagents |
|||
| RMF427CKC | Antigenix America | - | Ask for price |
Mouse EGF Construction Kit w/Developing Reagents |
|||
| RMF437CKC | Antigenix America | - | Ask for price |
Rat VEGF Construcition Kit w/Developing Reagents |
|||
| RRF501CKC | Antigenix America | - | Ask for price |
Pre-Titrated Reagents for Human MCP-1 ELISA |
|||
| MBS590075-10Plates | MyBiosource | 10Plates | EUR 710 |
Pre-Titrated Reagents for Human MCP-1 ELISA |
|||
| MBS590075-5Plates | MyBiosource | 5Plates | EUR 520 |
Pre-Titrated Reagents for Human MCP-1 ELISA |
|||
| MBS590075-5x10Plates | MyBiosource | 5x10Plates | EUR 3270 |
Pre-Titrated Reagents for Human MCP-3 ELISA |
|||
| MBS590077-10Plates | MyBiosource | 10Plates | EUR 710 |
Pre-Titrated Reagents for Human MCP-3 ELISA |
|||
| MBS590077-5Plates | MyBiosource | 5Plates | EUR 520 |
Pre-Titrated Reagents for Human MCP-3 ELISA |
|||
| MBS590077-5x10Plates | MyBiosource | 5x10Plates | EUR 3270 |
Pre-Titrated Reagents for Human IL-16 ELISA |
|||
| MBS590080-10Plates | MyBiosource | 10Plates | EUR 710 |
Pre-Titrated Reagents for Human IL-16 ELISA |
|||
| MBS590080-5Plates | MyBiosource | 5Plates | EUR 520 |
Pre-Titrated Reagents for Human IL-16 ELISA |
|||
| MBS590080-5x10Plates | MyBiosource | 5x10Plates | EUR 3270 |
Pre-Titrated Reagents for Human IL-18 ELISA |
|||
| MBS590083-10Plates | MyBiosource | 10Plates | EUR 710 |
Pre-Titrated Reagents for Human IL-18 ELISA |
|||
| MBS590083-5Plates | MyBiosource | 5Plates | EUR 520 |
Pre-Titrated Reagents for Human IL-18 ELISA |
|||
| MBS590083-5x10Plates | MyBiosource | 5x10Plates | EUR 3270 |
Human VEGF-B ELISA Kit w/Developing Reagents |
|||
| RH644CKC | Antigenix America | - | Ask for price |
Human PD-L1 ELISA kits w/Developing Reagents |
|||
| RHF642CKC | Antigenix America | - | Ask for price |
Human VEGF Construction Kit w/Developing Reagents |
|||
| RH88820CKC | Antigenix America | - | Ask for price |
Human BRAK Construction Kit w/Developing Reagents |
|||
| RHF123CKC | Antigenix America | - | Ask for price |
Human GDNF Construction Kit w/Developing Reagents |
|||
| RHF240CKC | Antigenix America | - | Ask for price |
Human BDNF Construction Kit w/Developing Reagents |
|||
| RHF270CKC | Antigenix America | - | Ask for price |
Human CTGF Construction Kit w/Developing Reagents |
|||
| RHF461CKC | Antigenix America | - | Ask for price |
Human TSLP Construction Kit w/Developing Reagents |
|||
| RHF466CKC | Antigenix America | - | Ask for price |
Human sDLL Construction Kit w/Developing Reagents |
|||
| RHF505CKC | Antigenix America | - | Ask for price |
Human TARC Construction Kit w/Developing Reagents |
|||
| RHF640CKC | Antigenix America | - | Ask for price |
Human TFF2 Construction Kit w/Developing Reagents |
|||
| RHF652CKC | Antigenix America | - | Ask for price |
Human TECK Construction Kit w/Developing Reagents |
|||
| RHF750CKC | Antigenix America | - | Ask for price |
Engineering caspase 7 as an affinity reagent to capture proteolytic products
- This was accomplished with only three substitutions within the substrate binding cleft. Moreover, the affinity of the product trap for peptides was comparable to the affinity of caspase 7 to parental substrates.
- Finally, generation of a hybrid fluorescent protein with the product trap provided a reagent that specifically recognized apoptotic cells and highlights the versatility of such an approach in developing affinity and imaging agents for a variety of cysteine and serine proteases.
Leveraging nature’s biomolecular designs in next-generation protein sequencing reagent development
When selectively bound to a specific N-terminal amino acid, the NAAB (N-terminal amino acid binder) affinity reagent identifies the amino acid through its associated fluorescence tag. A key technical challenge in implementing this fluoro-sequencing approach is the need to develop NAAB affinity reagents with the high affinity and selectivity for specific N-terminal amino acids required for this biotechnology application.
One approach to develop such a NAAB affinity reagent is to leverage naturally occurring biomolecules that bind amino acids and/or peptides. Here, we describe several candidate biomolecules that could be considered for this purpose and discuss the potential for developability of each.
Key points • Next-generation sequencing methods are emerging that could revolutionize proteomics. • Sequential readout of N-terminal amino acids by fluorescent-tagged affinity reagents. • Native peptide/amino acid binders can be engineered into affinity reagents. • Protein size and structure contribute to feasibility of reagent developability.
3-Epikatonic acid |
|||
| TN2931-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: 3-Epikatonic acid |
|||
3-Epikatonic acid |
|||
| TN2931-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: 3-Epikatonic acid |
|||
3-Epikatonic acid |
|||
| TB01910 | ChemNorm | 5mg | EUR 1016.4 |
16-Epikoumidine |
|||
| TN6036-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: 16-Epikoumidine |
|||
16-Epikoumidine |
|||
| TN6036-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: 16-Epikoumidine |
|||
16-Epikoumidine |
|||
| TN6036-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: 16-Epikoumidine |
|||
16-Epikoumidine |
|||
| TN6036-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: 16-Epikoumidine |
|||
16-Epikoumidine |
|||
| TN6036-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: 16-Epikoumidine |
|||
16-Epikoumidine |
|||
| TTE1328 | ChemNorm | unit | Ask for price |
3-Epikarounidiol |
|||
| TBZ1276 | ChemNorm | unit | Ask for price |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) |
|||
| MBS6005618-02mL | MyBiosource | 0.2(mL | EUR 695 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) |
|||
| MBS6005618-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (AP) |
|||
| MBS6333596-02mL | MyBiosource | 0.2mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (AP) |
|||
| MBS6333596-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (APC) |
|||
| MBS6333597-02mL | MyBiosource | 0.2mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (APC) |
|||
| MBS6333597-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (FITC) |
|||
| MBS6333599-02mL | MyBiosource | 0.2mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (FITC) |
|||
| MBS6333599-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (PE) |
|||
| MBS6333606-02mL | MyBiosource | 0.2mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (PE) |
|||
| MBS6333606-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358) |
|||
| REC32058-100 | The Native Antigen Company | 0.1 | EUR 280.67 |
|
Description: Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358) |
|||
Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358) |
|||
| REC32058-500 | The Native Antigen Company | 0.5 | EUR 1182.63 |
|
Description: Influenza A/Duck/Egypt/AR526/2017 (EPI_ISL_344529) nucleoprotein (EPI1420358) |
|||
Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385) |
|||
| REC32055-100 | The Native Antigen Company | 0.1 | EUR 311.28 |
|
Description: Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385) |
|||
Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385) |
|||
| REC32055-500 | The Native Antigen Company | 0.5 | EUR 1182.63 |
|
Description: Influenza A/chicken/Scotland/054477/2021 (EPI_ISL_9012696) nucleoprotein (EPI1963385) |
|||
Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898) |
|||
| REC32056-100 | The Native Antigen Company | 0.1 | EUR 311.28 |
|
Description: Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898) |
|||
Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898) |
|||
| REC32056-500 | The Native Antigen Company | 0.5 | EUR 1182.63 |
|
Description: Influenza A/Greylag_goose/England/054503/2021 (EPI_ISL_9029965) nucleoprotein (EPI1963898) |
|||
Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703) |
|||
| REC32059-100 | The Native Antigen Company | 0.1 | EUR 280.67 |
|
Description: Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703) |
|||
Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703) |
|||
| REC32059-500 | The Native Antigen Company | 0.5 | EUR 1182.63 |
|
Description: Influenza A/Cambodia/NPH230032/2023 (EPI_ISL_17024123) nucleoprotein (EPI2419703) |
|||
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366) |
|||
| REC32057-100 | The Native Antigen Company | 0.1 | EUR 280.67 |
|
Description: Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366) |
|||
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366) |
|||
| REC32057-500 | The Native Antigen Company | 0.5 | EUR 1182.63 |
|
Description: Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) nucleoprotein (EPI2076366) |
|||
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) hemagglutinin (EPI2076373) |
|||
| REC32060-100 | The Native Antigen Company | 0.1 | EUR 298.53 |
|
Description: Influenza A/Greylag_goose/Scotland/024915/2022 hemagglutinin, C-terminally tagged with a T4 fooldon domain to stabilize trimer s. |
|||
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) hemagglutinin (EPI2076373) |
|||
| REC32060-500 | The Native Antigen Company | 0.5 | EUR 1047.4 |
|
Description: Influenza A/Greylag_goose/Scotland/024915/2022 hemagglutinin, C-terminally tagged with a T4 fooldon domain to stabilize trimer s. |
|||
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372) |
|||
| REC32061-100 | The Native Antigen Company | 0.1 | EUR 298.53 |
|
Description: Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372), expressed in HEK293 cells and purified from culture supernatant. The protein is stabilized as a tetramer via an N-terminal tetrabrachion domain |
|||
Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372) |
|||
| REC32061-500 | The Native Antigen Company | 0.5 | EUR 1047.4 |
|
Description: Influenza A/Greylag_goose/Scotland/024915/2022 (EPI_ISL_13486869) neuraminidase (EPI2076372), expressed in HEK293 cells and purified from culture supernatant. The protein is stabilized as a tetramer via an N-terminal tetrabrachion domain |
|||
EPI-7170 |
|||
| HY-150102 | MedChemExpress | 10 mg | EUR 1590.93 |
|
Description: EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 has antitumor effects against enzalutamide resistant castration-resistant prostate cancer (CRPC)[1]. |
|||
EPI-7170 |
|||
| T63811-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EPI-7170 |
|||
EPI-7170 |
|||
| T63811-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EPI-7170 |
|||
EPI-7170 |
|||
| T63811-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EPI-7170 |
|||
EPI-7170 |
|||
| T63811-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EPI-7170 |
|||
EPI-7170 |
|||
| T63811-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EPI-7170 |
|||
EPI-001 |
|||
| 555572 | MedKoo Biosciences | 10.0mg | EUR 250 |
EPI-001 |
|||
| B6041-10 | ApexBio | 10 mg | EUR 56 |
|
Description: Endocrinology and Hormones|Androgen Receptor |
|||
EPI-001 |
|||
| B6041-200 | ApexBio | 200 mg | EUR 376 |
|
Description: Endocrinology and Hormones|Androgen Receptor |
|||
EPI-001 |
|||
| B6041-50 | ApexBio | 50 mg | EUR 168 |
|
Description: Endocrinology and Hormones|Androgen Receptor |
|||
EPI-001 |
|||
| MBS131396-100mg | MyBiosource | 100mg | EUR 1495 |
EPI-001 |
|||
| HY-100348 | MedChemExpress | 10 mg | EUR 333.34 |
|
Description: EPI-001, a selective inhibitor of Androgen Receptor (AR), targets transactivation unit 5 (Tau-5) of the AR. EPI-001 can inhibit transactivation of the AR amino-terminal domain (NTD), with an IC50 of ~6 μM. EPI-001 is also a selective modulator of PPARγ. EPI-001 is active against castration-resistant prostate cancer[1][2][3]. |
|||
EPI-743 |
|||
| HY-16772 | MedChemExpress | 10 mg | EUR 1028.15 |
|
Description: EPI-743 (Vatiquinone; α-Tocotrienol quinone; PTC-743; NCT04378075) is a potent cellular oxidative stress protectant, inhibits ferroptosis in cells, which could be used for the study for mitochondrial diseases. EPI-743 is a synthetic analog of vitamin E with oral activity, targets repletion of reduced intracellular glutathione[1][2]. |
|||
EPI-589 |
|||
| HY-125999 | MedChemExpress | 10 mg | EUR 432.91 |
|
Description: EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS)[1]. |
|||
EPI-001 |
|||
| MBS384678-10mg | MyBiosource | 10mg | EUR 160 |
EPI-001 |
|||
| MBS384678-25mg | MyBiosource | 25mg | EUR 240 |
EPI-001 |
|||
| MBS384678-50mg | MyBiosource | 50mg | EUR 300 |
EPI-001 |
|||
| MBS384678-5x50mg | MyBiosource | 5x50mg | EUR 1340 |
EPI-589 |
|||
| MBS5766602-5mg | MyBiosource | 5mg | EUR 915 |
EPI-589 |
|||
| MBS5766602-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
EPI-589 |
|||
| T11214-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EPI-589 |
|||
EPI-589 |
|||
| T11214-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EPI-589 |
|||
EPI-589 |
|||
| T11214-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EPI-589 |
|||
EPI-589 |
|||
| T11214-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EPI-589 |
|||
EPI-589 |
|||
| T11214-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EPI-589 |
|||
EPI-001 |
|||
| T6829-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EPI-001 |
|||
EPI-001 |
|||
| T6829-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EPI-001 |
|||
EPI-001 |
|||
| T6829-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EPI-001 |
|||
EPI-001 |
|||
| T6829-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EPI-001 |
|||
EPI-001 |
|||
| T6829-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EPI-001 |
|||
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Biotin) |
|||
| MBS6333598-02mL | MyBiosource | 0.2mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Biotin) |
|||
| MBS6333598-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Azide free) (HRP) |
|||
| MBS6333600-02mL | MyBiosource | 0.2mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (Azide free) (HRP) |
|||
| MBS6333600-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 405) |
|||
| MBS6333601-01mL | MyBiosource | 0.1mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 405) |
|||
| MBS6333601-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 490) |
|||
| MBS6333602-01mL | MyBiosource | 0.1mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 490) |
|||
| MBS6333602-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 550) |
|||
| MBS6333603-01mL | MyBiosource | 0.1mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 550) |
|||
| MBS6333603-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 650) |
|||
| MBS6333604-01mL | MyBiosource | 0.1mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 650) |
|||
| MBS6333604-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 750) |
|||
| MBS6333605-01mL | MyBiosource | 0.1mL | EUR 980 |
PI3KC3, CT (E785) (PIK3C3, VPS34, Phosphatidylinositol 3-kinase catalytic subunit type 3, Phosphatidylinositol 3-kinase p100 subunit, Phosphoinositide-3-kinase class 3, hVps34) (MaxLight 750) |
|||
| MBS6333605-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag |
|||
| REC32038-100 | The Native Antigen Company | 0.1 | EUR 301.29 |
|
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023. |
|||
Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag |
|||
| REC32038-500 | The Native Antigen Company | 0.5 | EUR 1057.09 |
|
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1942222), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023. |
|||
Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag |
|||
| REC32039-100 | The Native Antigen Company | 0.1 | EUR 301.29 |
|
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023. |
|||
Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag |
|||
| REC32039-500 | The Native Antigen Company | 0.5 | EUR 1057.09 |
|
Description: Influenza A/Sydney/5/2021 (H1N1)pdm09-like virus HA (EPI1957293), C-terminal T4 foldon, His-tag. This product is part of the WHO vaccine composition recommendation for influenza virus for the Southern hemisphere 2023. |
|||
EPI300 Glycerol Stock |
|||
| D0357 | Beyotime Biotech Inc | 200 μL | Ask for price |
EPI300 Super Competent Cells |
|||
| D1035M | Beyotime Biotech Inc | 50x 100 μL | Ask for price |
EPI300 Super Competent Cells |
|||
| D1035S | Beyotime Biotech Inc | 10x 100 μL | Ask for price |
